Sulfamides as Endothelin Receptor Antagonists for the Treatment of Cardiovascular Diseases
申请人:Bolli Martin
公开号:US20080004298A1
公开(公告)日:2008-01-03
The invention relates to novel sulfamic acid amides and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing one or more of those compounds and especially their use as endothelin receptor antagonists.
本发明涉及新型磺酰胺酸酯及其在制备药物组成物中作为活性成分的用途。本发明还涉及相关方面,包括含有这些化合物中的一个或多个的药物组成物,特别是它们作为内皮素受体拮抗剂的用途。